Kristine Glunde
Kristine Glunde
The Johns Hopkins University School of Medicine
Verified email at - Homepage
Cited by
Cited by
Choline metabolism in malignant transformation
K Glunde, ZM Bhujwalla, SM Ronen
Nature Reviews Cancer 11 (12), 835-848, 2011
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer
K Glunde, C Jie, ZM Bhujwalla
Cancer research 64 (12), 4270-4276, 2004
Choline phospholipid metabolism: a target in cancer cells?
E Ackerstaff, K Glunde, ZM Bhujwalla
Journal of cellular biochemistry 90 (3), 525-533, 2003
Extracellular acidification alters lysosomal trafficking in human breast cancer cells
K Glunde, SE Guggino, M Solaiyappan, AP Pathak, Y Ichikawa, ...
Neoplasia 5 (6), 533-545, 2003
Choline metabolism in cancer: implications for diagnosis and therapy
K Glunde, MA Jacobs, ZM Bhujwalla
Expert review of molecular diagnostics 6 (6), 821-829, 2006
RNA interference–mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation
K Glunde, V Raman, N Mori, ZM Bhujwalla
Cancer research 65 (23), 11034-11043, 2005
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells
E Iorio, A Ricci, M Bagnoli, ME Pisanu, G Castellano, M Di Vito, ...
Cancer research 70 (5), 2126-2135, 2010
Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism
K Glunde, NJ Serkova
Future Medicine Ltd 7 (7), 1109-1123, 2006
Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions
K Glunde, E Ackerstaff, N Mori, MA Jacobs, ZM Bhujwalla
Molecular pharmaceutics 3 (5), 496-506, 2006
Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1α signaling in a human prostate cancer model
K Glunde, T Shah, PT Winnard, V Raman, T Takagi, F Vesuna, D Artemov, ...
Cancer research 68 (1), 172-180, 2008
Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models
K Chughtai, L Jiang, TR Greenwood, K Glunde, RMA Heeren
Journal of lipid research 54 (2), 333-344, 2013
Concise representation of mass spectrometry images by probabilistic latent semantic analysis
M Hanselmann, M Kirchner, BY Renard, ER Amstalden, K Glunde, ...
Analytical chemistry 80 (24), 9649-9658, 2008
Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer
K Glunde, D Artemov, MF Penet, MA Jacobs, ZM Bhujwalla
Chemical reviews 110 (5), 3043-3059, 2010
Metabolic tumor imaging using magnetic resonance spectroscopy
K Glunde, ZM Bhujwalla
Seminars in oncology 38 (1), 26-41, 2011
Molecular–functional imaging of cancer: to image and imagine
K Glunde, AP Pathak, ZM Bhujwalla
Trends in molecular medicine 13 (7), 287-297, 2007
PSMA-targeted theranostic nanoplex for prostate cancer therapy
Z Chen, MF Penet, S Nimmagadda, C Li, SR Banerjee, PT Winnard Jr, ...
ACS nano 6 (9), 7752-7762, 2012
Metabolomics of cancer
NJ Serkova, K Glunde
Tumor biomarker discovery, 273-295, 2009
1.2-to 2.2-μm tunable Raman soliton source based on a Cr: forsterite laser and a photonic-crystal fiber
MC Chan, SH Chia, TM Liu, TH Tsai, MC Ho, AA Ivanov, AM Zheltikov, ...
IEEE Photonics Technology Letters 20 (11), 900-902, 2008
Molecular and functional imaging of cancer: advances in MRI and MRS
AP Pathak, B Gimi, K Glunde, E Ackerstaff, D Artemov, ZM Bhujwalla
Methods in enzymology 386, 1-58, 2004
MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer
K Glunde, L Jiang, SA Moestue, IS Gribbestad
NMR in biomedicine 24 (6), 673-690, 2011
The system can't perform the operation now. Try again later.
Articles 1–20